JOURNAVX®: Opioid-Free Recovery Post-Surgery Data Revealed
New Phase 4 data shows Vertex’s JOURNAVX® (suzetrigine) enables 76% opioid-free recovery after laparoscopic & arthroscopic surgeries in multimodal therapy. Reduces opioid use.
-
-
Future of Chronic Pain: Centralized, Multimodal, & Digital Care
Explore 2026 insights on chronic pain, focusing on centralized pain mechanisms, multimodal treatment strategies, complementary therapies, and the ethical integration of eHealth solutions for improved patient care.
